GHW International

Research GHW International (9933.HK) on Bullrun: market cap HKD 1.56B, P/E 41.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 1.56B; P/E is 41.3.

Peer valuation comparison

Latest P/E is 41.25x versus a Basic Materials sector median of 15.25x (170.5% above).

Latest P/E is 41.25x versus a China median of 16.26x (153.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 4.11BCNY 12.72MCNY 95.31M8.8%n/aCNY 115.84MCNY 821.90MCNY 599.19M
FY2024CNY 3.86BCNY 12.75M-CNY 95.58M10.1%0.01CNY 101.46MCNY 862.35MCNY 585.78M
FY2023CNY 3.22BCNY 2.72M-CNY 19.81M10.5%0CNY 77.39MCNY 718.32MCNY 581.42M
FY2022CNY 3.38BCNY 274.63M-CNY 50.28M19.5%0.27CNY 103.18MCNY 663.43MCNY 602.62M
FY2021n/an/an/an/a0.13n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 1.56B41.3n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About GHW International

GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People's Republic of China, Europe, Vietnam, the rest of Asia, and internationally. It operates through seven segments: Methylamine Industry Series; Goldenhighway New Materials; Advanced Materials Intermediates Series; Green Products; Healthcare and Wellness; Iodine Derivatives and Supporting Products; and Happy Elephant Selections.

Related stock research

Other Basic Materials stocks

Frequently asked questions

What is GHW International's market cap?

GHW International's market capitalization is HKD 1.56B.

What is GHW International's P/E ratio?

GHW International's price-to-earnings (P/E) ratio is 41.3.

What does GHW International do?

GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People's Republic of China, Europe, Vietnam, the rest of Asia, and internationally. It operates through seven segments: Methylamine Industry Series; Goldenhighway New Materials; Advanced Materials Intermediates Series; Green Products; Healthcare and Wellness; Iodine Derivatives and Supporting Products; and Happy Elephant Selections. The Methylamine Industry Series segment consists of animal nutrition chemical products, such as choline chloride and betaine.